Faculty Publications Spotlight Advances in Prostate Cancer Treatment, Screening, and Antibiotic Stewardship

New research published in January 2025 from faculty in the Department of Urology highlights advancements in prostate cancer treatment, including the long-term success of Cs-131 brachytherapy, personalized approaches to screening, and innovative antibiotic stewardship strategies to improve patient care. 

Prostate Brachytherapy With Cs-131: Long-term Results Compared With Published Stereotactic Body Radiotherapy Data

• American Journal of Clinical Oncology
• This study evaluates the long-term outcomes of prostate cancer treatment using Cesium-131 (Cs-131) brachytherapy and compares these results to those from stereotactic body radiotherapy (SBRT). The research highlights Cs-131's efficacy in localized prostate cancer management, emphasizing comparable or superior long-term control, side effects, and quality-of-life outcomes relative to SBRT.

Controversies in Prostate Cancer Screening

• Urology Practice
• This publication reviews the ongoing debates surrounding prostate cancer screening, particularly focusing on PSA (prostate-specific antigen) testing. It discusses the benefits of early detection against the risks of overdiagnosis, overtreatment, and related complications, advocating for personalized screening strategies that balance patient-specific factors with evidence-based guidelines.

Implementing Change Through an Outpatient Antibiotic Stewardship Program

• Urology Practice
• This research outlines the design and outcomes of an outpatient antibiotic stewardship program aimed at improving antibiotic prescribing practices. It emphasizes the importance of multidisciplinary approaches, provider education, and patient engagement in reducing antibiotic misuse, promoting evidence-based practices, and combating antimicrobial resistance.